Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Alprazolam

Known as: 4H-(1,2,4)Triazolo(4,3-a)(1,4)benzodiazepine, 8-chloro-1-methyl-6-phenyl-, Alprazolan, Alprazolam [Chemical/Ingredient] 
A triazolobenzodiazepine agent with anxiolytic, sedative-hypnotic and anticonvulsant activities. Alprazolam binds to a specific site distinct from… Expand
National Institutes of Health

Related topics

Related topics

33 relations
24 HR Alprazolam 1 MG Extended Release Oral TabletAgoraphobiaAlprazolam 0.25 MG Oral TabletAlprazolam 1 MG Disintegrating Oral Tablet
Expand

Narrower (10)

4-hydroxyalprazolamAlproxCassadanD-65MT
Expand

Broader (5)

Anti-Anxiety AgentsBenzodiazepineGABA ModulatorsHypnotics and Sedatives
Expand

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Highly Cited
2014
Highly Cited
2014
A randomized, double-blind evaluation of D-cycloserine or alprazolam combined with virtual reality exposure therapy for posttraumatic stress disorder in Iraq and Afghanistan War veterans.
OBJECTIVE The authors examined the effectiveness of virtual reality exposure augmented with D-cycloserine or alprazolam, compared… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
  • figure 2
Highly Cited
2005
Highly Cited
2005
Pregabalin for treatment of generalized anxiety disorder: a 4-week, multicenter, double-blind, placebo-controlled trial of pregabalin and alprazolam.
BACKGROUND Pregabalin inhibits release of excess excitatory neurotransmitters, presumably by binding to the alpha2-delta subunit… Expand
  • figure 1
  • table 1
  • table 2
  • table 3
  • figure 2
Highly Cited
2005
Highly Cited
2005
A double-blind study in healthy volunteers to assess the effects on sleep of pregabalin compared with alprazolam and placebo.
STUDY OBJECTIVES To assess the effects of pregabalin compared with alprazolam and placebo on aspects of sleep in healthy… Expand
Review
2000
Review
2000
Pharmacokinetic-Pharmacodynamic Consequences and Clinical Relevance of Cytochrome P450 3A4 Inhibition
Drug interactions occur when the efficacy or toxicity of a medication is changed by administration of another substance… Expand
Review
1998
Review
1998
Herbal medicinals: selected clinical considerations focusing on known or potential drug-herb interactions.
  • L. G. Miller
  • Archives of internal medicine
  • 1998
    • Corpus ID: 6396336
Herbal medicinals are being used by an increasing number of patients who typically do not advise their clinicians of concomitant… Expand
Review
1997
Review
1997
The olfactory bulbectomized rat as a model of depression: an update.
The olfactory bulbectomized (OB) rat has been proposed as an animal model of depression. The following behavioural changes have… Expand
Highly Cited
1996
Highly Cited
1996
Coma from the Health Food Store: Interaction between Kava and Alprazolam
TO THE EDITOR: Millions of Americans use drugs sold in health food stores, yet most of these agents are unregulated. The… Expand
Highly Cited
1993
Highly Cited
1993
Alprazolam and exposure alone and combined in panic disorder with agoraphobia. A controlled study in London and Toronto.
A cross-national randomised trial of alprazolam for chronic panic disorder with agoraphobia was run. Compared with previous… Expand
  • table 1
  • table 3
  • figure 1
  • figure 2
  • figure 3
Highly Cited
1988
Highly Cited
1988
Alprazolam in panic disorder and agoraphobia: results from a multicenter trial. I. Efficacy in short-term treatment.
Following promising preliminary evidence, the benzodiazepine-derivative alprazolam was studied in a large, placebo-controlled… Expand
Highly Cited
1988
Highly Cited
1988
Pharmacotherapy of borderline personality disorder. Alprazolam, carbamazepine, trifluoperazine, and tranylcypromine.
Sixteen female outpatients with borderline personality disorder and prominent behavioral dyscontrol, but without a current… Expand
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy, Terms of Service, and Dataset License
ACCEPT & CONTINUE